Genflow
1open role
$11Mraised in 5 rounds
A-ratedvisa sponsor licence, United Kingdom
10+people
Overview
We help creators and online entreprenuers monetize their audiences. We provide a 360 experience to enable creators to grow their audience, launch their own businesses, deliver brand partnerships and unlock their true potential.
Key facts
As of Nov 12, 2026, Alion lists 1 open role at Genflow. Genflow is headquartered in London, United Kingdom. It was founded in 2016. The latest round is Venture - Series Unknown of $11M, announced in 2021.
- Open roles
- 1Job postings Alion tracks, as of Nov 12, 2026
- Headquarters
- London, United KingdomAlion company profile, updated Nov 12, 2026
- Founded
- 2016Alion company profile, updated Nov 12, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $11MSum of 1 equity round Alion knows
- Latest round
- Venture - Series Unknown · $11M · Jan 21, 2021Press report · techcrunch.com
- Visa sponsorship, United Kingdom
- A-ratedUK Home Office · checked Nov 12, 2026
How to cite this page
Alion, "Genflow: key facts", as of Nov 12, 2026. https://alion.io/company/genflow
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0
Jobs
No jobs available at this time.
Visa sponsorship
A-rated
Sponsor licence
Skilled Worker
Visa route
1
Open roles in United Kingdom
In the register as Genflow LTD, London
See 1 open role Alert me
UK Home Office · checked Nov 12, 2026 · Visa details by country
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~6 hours
11/12/2026
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
100% ▼
Financials
Total raised
$11M
Latest round
Venture - Series Unknown
Funding rounds
5
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
BGFVia a fund
406 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Genflow CEO: SLAB trial hits endpoint, a
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire spoke with Proactive
Read more
Report
Genflow Biosciences, EnergyPathways, Itaconix, Gaming Realms, Total Graphite, 80 Mile
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) says its SLAB gene therapy trial in ageing dogs has hit its primary endpoint. It
Read more
Report
Genflow Biosciences expands SIRT6 patent protection into muscular diseases
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the gene therapy developer, has announced the international publication of a Patent Cooperation Treaty (PCT) application covering variants of the SIRT6 protein for the treatment of muscular disease
Read more
Report
Genflow Biosciences confirms receipt of €4m grant installment
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has received the first instalment of its €4 million non-dilutive grant from Belgium's Wallonia Region, a funding package designed to support a three-year development programme. The company said the
Read more
Report
Genflow CEO outlines 2026 priorities as €4 million grant is approved
Markets and small-cap news.
Read more
Report
Baidu Wenku and Netdisk Launch GenFlow 2.0, Deploying Over 100 AI Agents Simultaneously
Baidu Wenku and Netdisk, Baidu
Read more
Report
Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024
Genflow expanded its intellectual property portfolio with a provisional patent application for editing the SIRT6 gene, linked to longevity and age-related diseases. Began trading on the OTCQB Venture Market in the US under the ticker GENFF, aligned to its
Read more
Report
Genflow Biosciences Partners with Revatis SA and EXO Biologics in Groundbreaking Aging Research, Fueled by Two Major Research Grants (2024-01-18)
--Genflow Biosciences Plc, an emerging leader in the field of longevity research developing therapeutics that potentially halt or slow the ageing process, in collaboration with Revatis SA and EXO Biologics, is proud to announce the initiation of two signi
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
London
London
United Kingdom
HQ
1 open roles 10-50 est. staff
hires for Administrative